|
End-of-day quote
Nasdaq Stockholm
|
||
| - SEK | - |
|
| 03-02 | SciBase Wins US FDA Nod for Skin Cancer Detection Device Label Expansion | MT |
| 11-07 | SciBase, Castle Biosciences Expand License Deal, Secures SEK20 Million Loan | MT |
| Manager | Title | Age | Since |
|---|---|---|---|
Pia Renaudin
CEO | Chief Executive Officer | 59 | 01/10/2023 |
Michael Colérus
DFI | Director of Finance/CFO | 64 | 01/01/2014 |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Diana Ferro
BRD | Director/Board Member | 60 | 16/05/2017 |
Jesper Høiland
CHM | Chairman | 66 | 13/06/2024 |
| Director/Board Member | 68 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +6.05% | +5.87% | +25.71% | -29.73% | 17.02B | |
| +4.68% | -7.33% | -39.72% | +98.25% | 1.61B | |
| +0.52% | -1.25% | -22.93% | +26.06% | 978M | |
| +7.61% | -1.59% | -43.62% | -80.01% | 946M | |
| +0.16% | -0.05% | +64.65% | -7.23% | 778M | |
| +5.55% | +1.81% | -35.43% | -46.60% | 667M | |
| -2.07% | -7.48% | -42.69% | -43.27% | 589M | |
| -1.79% | +5.01% | -42.85% | -36.73% | 450M | |
| +1.07% | +2.37% | +73.08% | +47.65% | 423M | |
| Average | +2.42% | -0.82% | -7.09% | -7.96% | 2.61B | |
| Weighted average by Cap. | +5.13% | +3.55% | +13.77% | -19.46% |
Employees
-
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
